| Literature DB >> 3368243 |
R G Wells1, F G Seidel, J R Sty, H M Swick.
Abstract
An open label, noncomparative clinical trial of intrathecal iopamidol in children was performed. Sixty-one subjects between the ages of 24 days and 17 years were studied. Opacification of the subarachnoid space was adequate in all cases. Mild adverse reactions were detected in 10% of the participants. Seizures, EEG alterations or other severe reactions did not occur. The findings confirm the efficacy and safety of iopamidol as an intrathecal contrast medium in pediatrics.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3368243 DOI： 10.1007/bf02390393
Source DB: PubMed Journal: Pediatr Radiol ISSN： 0301-0449